Dermata Therapeutics Inc (DRMA)
4.20
-1.00
(-19.23%)
USD |
NASDAQ |
May 17, 16:00
4.40
+0.20
(+4.76%)
After-Hours: 20:00
Dermata Therapeutics Shareholders Equity (Quarterly): 3.808M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.808M |
| December 31, 2023 | 6.355M |
| September 30, 2023 | 6.407M |
| June 30, 2023 | 8.03M |
| March 31, 2023 | 8.088M |
| December 31, 2022 | 6.022M |
| September 30, 2022 | 7.471M |
| Date | Value |
|---|---|
| June 30, 2022 | 9.66M |
| March 31, 2022 | 7.852M |
| December 31, 2021 | 10.11M |
| September 30, 2021 | 45.92M |
| June 30, 2021 | -0.5058M |
| March 31, 2021 | 0.712M |
| December 31, 2020 | 0.00 |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.5058M
Minimum
Jun 2021
45.92M
Maximum
Sep 2021
8.566M
Average
6.939M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.180M |
| Total Liabilities (Quarterly) | 1.372M |